№ lp_2_3_66422
File format: docx
Character count: 102342
File size: 1880 KB
Guidelines for the development and adaptation of national PrEP protocols, based on WHO recommendations for oral, vaginal, and injectable pre-exposure prophylaxis.
Year:
2024
Region / city:
Global
Theme:
HIV Prevention, Pre-exposure Prophylaxis (PrEP)
Document type:
Guideline
Organization:
WHO, USAID, Global Fund
Author:
MOSAIC, FHI 360
Target audience:
National policymakers, healthcare providers
Period of validity:
Ongoing
Approval date:
October 2024
Modification date:
October 2024
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
Global
Topic:
HIV Prevention
Document Type:
Guidelines
Organization / Institution:
WHO, MOSAIC, USAID, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Author:
MOSAIC, WHO, USAID
Target Audience:
Policymakers, health professionals
Period of Validity:
Ongoing
Approval Date:
October 2024
Date of Updates:
October 2024
Document Type:
Quarterly health facility cohort reporting form
Subject:
Pre-Exposure Prophylaxis (PrEP) service delivery and client outcomes
Reporting Level:
Health facility
Geographic Scope:
District and Province/Region fields included
Reporting Period:
Quarterly (ending month and year specified)
Population Covered:
All PrEP clients and key populations (MSM, TG, SW, PWID)
Data Elements:
Cohort size, transfers, follow-up status, HIV testing, discontinuation reasons, loss to follow-up, deaths
Cohort Definition:
Clients grouped by calendar month and year of PrEP initiation
Disaggregation:
By months since PrEP initiation (1, 3, 6, 9, 12 months) and population category
Indicators:
Percent alive and on PrEP, percent tested for HIV, percent testing HIV-positive, percent no longer at substantial risk, percent lost to follow-up
Responsible Parties:
Form completed by and verified by (name, title, date fields included)
Year:
2023
Region / City:
United Kingdom
Topic:
Course Assessment Procedures
Document Type:
Policy Guide
Institution:
University
Target Audience:
Academic Staff, Course Administrators, Data Returns Managers
Period of Validity:
Academic Year 2023/2024
Approval Date:
N/A
Date of Changes:
N/A
Year:
2024
Region / City:
Global
Topic:
HIV Prevention
Document Type:
Guidelines
Organization / Institution:
WHO, MOSAIC, USAID, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Author:
MOSAIC, WHO, USAID
Target Audience:
Policymakers, health professionals
Period of Validity:
Ongoing
Approval Date:
October 2024
Date of Updates:
October 2024
Note:
Year
Note:
Year
Context:
Report detailing the assessment process for an accredited laboratory, including nonconformities and compliance evaluations.
Year:
2023
Region / City:
Northern Savings Credit Union
Topic:
IT Change Management
Document Type:
Guidelines
Organization:
Northern Savings Credit Union
Author:
Northern Savings Change Management Team
Target Audience:
Change Managers, CAB members, IT staff
Effective Period:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Date:
April 18, 2025
Time:
9:30 a.m. - 11:30 p.m.
Location:
4600 Broadway, Community Room 2020, Sacramento, CA
Type of Document:
Meeting Agenda
Organization:
Sacramento County Department of Health Services
Audience:
CAB Members, General Public
Meeting Type:
Regular Meeting
Purpose:
CAB Meeting
Event:
Health Center Co-Applicant Board Meeting
Participants:
Suhmer Fryer (Chair), CAB Members
Additional Information:
The meeting will also be accessible via teleconference for members unable to attend in person.
Organization:
WFAE Community Advisory Board (CAB)
Document Type:
Meeting Minutes
Date:
27 January 2022
Time:
5:30 pm
Location:
Zoom Meeting
Quorum:
Established
Chair:
Stephen Guardipee
Staff Present:
Jeff Bundy; Dante Miller; Sarah Mobley Smith; Jenn Lang; Renee Rallos; Maria Ramirez Uribe; Ju-Don Marshall; London Scott
Guests:
Fiona Morgan, Diana Quarry
Agenda Items:
Welcome; Approval of Minutes; Recruitment; Race & Equity Listening Session; Content Update; Station Update; CAB Member Feedback; Questions
Previous Minutes Approved:
October 2021
Topics Discussed:
Recruitment Process 2022; Community Engagement; Race & Equity Reporting; Content Strategy; Member Feedback
Geographic Focus:
Charlotte, North Carolina
Governing Body:
WFAE Community Advisory Board
Year:
2017-18
Region / City:
Not specified
Theme:
Community Advisory Boards, Cultural Competence
Document Type:
Questionnaire
Agency / Organization:
Not specified
Author:
Not specified
Target Audience:
Agency staff, program directors, community advisory board members
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
Not specified
Region / Jurisdiction:
United Nations regulatory framework
Subject:
Vehicle safety and protection of cab occupants
Document type:
Regulatory amendment proposal
Regulation referenced:
UN Regulation No. 29
Amendment series:
03 Series of Amendments
Proposed supplement:
Supplement 6
Organization:
UNECE World Forum for Harmonization of Vehicle Regulations
Working group:
GRSP (Working Party on Passive Safety)
Task force:
TF GRSP AVRS
Submitting country:
Germany
Scope:
Vehicles of category N and NX
Related technology:
Automated Driving System (ADS)
Key definitions introduced:
Automated Driving System (ADS), Dynamic Driving Task (DDT), Driver
Regulatory focus:
Type approval requirements and frontal impact testing conditions for vehicle cabs
Applicable vehicle configuration:
Cab-over-engine and vehicles with alternative cab positions in category NX
Year:
2026
Region / City:
Colombo, Sri Lanka
Subject:
Public vehicle procurement
Document Type:
Tender / Procurement Document
Organization:
Sri Lanka State Trading (General) Corporation Ltd
Author:
Department Procurement Committee
Target Audience:
Eligible local automotive suppliers
Procurement Method:
National Competitive Bidding
Bid Number:
STC/AD/vehicle Purchase-2026
Vehicle Types:
Hybrid SUV, Double Cab
Bid Security:
Rs. 350,000 for SUV, Rs. 400,000 for Double Cab
Bid Validity:
Until 05 June 2026
Bid Submission Deadline:
05 March 2026, 1100hrs
Information Access Period:
12 February 2026 – 04 March 2026
Language of Bidding Document:
English
Funding Source:
Government of the Democratic Socialist Republic of Sri Lanka
Participation Restriction:
Only authorized local agents, foreign bidders not allowed
Year:
circa 1900
Location:
London, United Kingdom
Theme:
Social interactions, urban life
Document type:
Play excerpt
Author:
George Bernard Shaw
Characters:
Mrs Eynsford-Hill, Clara, Freddy, Bystander, Flower Girl
Setting:
Evening, rainy street
Source:
English literature
Year:
2024
Region / City:
Global
Topic:
HIV Prevention, Post-exposure Prophylaxis
Document Type:
Guidelines
Organization / Institution:
MOSAIC, USAID, The Global Fund
Author:
MOSAIC Project
Target Audience:
Policymakers, Healthcare Providers
Period of Effectiveness:
Not specified
Approval Date:
December 2024
Date of Modifications:
Not specified
Contextual description:
Adaptable guidelines for developing and adopting national post-exposure prophylaxis protocols aligned with WHO recommendations, aimed at improving access and effectiveness of HIV prevention strategies.
Year:
2025
Region / City:
United Kingdom
Subject:
Influenza prophylaxis
Document Type:
Patient Group Direction (PGD)
Organisation:
UK Health Security Agency (UKHSA)
Author:
Shilan Ghafoor, Dr. Matthew Donati, Lesley McFarlane
Target Audience:
Healthcare practitioners
Effective Period:
08 August 2025 - 07 August 2028
Approval Date:
08 August 2025
Review Date:
08 August 2027
Expiry Date:
07 August 2028
Version:
6.0
Clinical Content Authorisation:
UKHSA
Amendments History:
See Change History
Relevant Legislation:
Human Medicines Regulations 2012 (HMR2012)
Context:
Document outlines a Patient Group Direction for the supply of oseltamivir for post-exposure prophylaxis of seasonal influenza for residents, users, and staff of care facilities in the UK, with specifications on authorisation, amendments, and use by healthcare practitioners.
Year:
2024
Region / City:
Global
Topic:
HIV Prevention
Document Type:
Guidelines
Organization / Institution:
WHO, MOSAIC, USAID, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Author:
MOSAIC, WHO, USAID
Target Audience:
Policymakers, health professionals
Period of Validity:
Ongoing
Approval Date:
October 2024
Date of Updates:
October 2024
Year:
2016
Region / city:
Oxford, Bristol, Nottingham, York
Theme:
Medical, Oncology
Document Type:
Guideline
Organization / institution:
John Radcliffe Hospital, Bristol Children’s Hospital, University of York
Author:
Rebecca Proudfoot, John Radcliffe Hospital, Rachel Cox, Bristol Children’s Hospital, Bob Phillips, University of York, Sophie Wilne, University Hospitals Nottingham NHS Trust
Target audience:
Healthcare professionals involved in pediatric oncology
Period of validity:
Ongoing recommendations
Approval Date:
July 2016
Date of revisions:
Not mentioned
Context:
Clinical guideline for the prevention of Pneumocystis Jirovecii Pneumonia in children with solid tumors undergoing oncological treatments.
Author:
Dr. Mark Bishton, Honorary Consultant Haematologist, Nottingham University [email protected]
Version:
Draftv1.2
Ratified by & Date:
EM Haematology ECAG 03/10/2025
Review date:
October 2027
Explicit definition of patient group to which it applies:
Patients with Lymphoma receiving steroid containing chemotherapy regimens
NICE guidance reference:
N/A
Note:
Summary of evidence base this guideline has been created from
Version No.:
1.0, 1.1, 1.2
Date:
March 2025, July, September
Revision Author:
M Bishton
Status:
Draft, FINAL
Description:
Updates on bisphosphonate use and recent ECAG review
Indication of prophylaxis:
Bisphosphonate prophylaxis for patients with at least 1 listed risk factor
Bisphosphonate agents:
Alendronic acid, Zolendronic acid, Risedronate, Denosumab
Adjunctive treatment:
Vitamin D supplementation required
Year:
2025
Region / City:
Massachusetts
Topic:
Lyme Disease, Postexposure Prophylaxis
Document Type:
Medical Guideline
Organization / Institution:
Massachusetts Department of Public Health
Author:
Massachusetts Department of Public Health
Target Audience:
Healthcare providers
Period of Effectiveness:
July 14, 2025
Approval Date:
July 14, 2025
Date of Changes:
N/A
Document type:
Clinical guideline appendix
Chapter:
8 Plastic Surgery
Appendix:
1
Subject:
Perioperative venous thromboembolism prophylaxis
Content:
Summary of the quality of studies
Focus:
Deep vein thrombosis (DVT) and pulmonary embolism (PE)
Population:
Patients undergoing plastic and reconstructive surgery
Interventions:
Chemoprophylaxis, mechanical prophylaxis, risk assessment models, anticoagulation strategies
Outcomes:
DVT incidence, VTE incidence, bleeding rate, free flap failure rate, mortality
Risk of bias assessment:
Low, Intermediate, High
Studies included:
Observational studies and comparative studies
Update status:
First update